RESEARCH-USE BIOSIMILAR ANTIBODY
Imsidolimab
Monoclonal antibody · IgG4
Imsidolimab (ANB 019) is a high-affinity, humanized monoclonal antibody of anti-IL-36R. Imsidolimab antagonizes IL-36 cytokine signal transduction. Imsidolimab has potential application in generalized pustular psoriasis (GPP) and other inflammatory skin diseases.
TARGETIL36R
YMonoclonal antibody
CATALOGSC-BS-480
CATALOG NUMBERSC-BS-480
MOLECULAR WEIGHTApprox. 146.6 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Imsidolimab (ANB 019) is a high-affinity, humanized monoclonal antibody of anti-IL-36R. Imsidolimab antagonizes IL-36 cytokine signal transduction. Imsidolimab has potential application in generalized pustular psoriasis (GPP) and other inflammatory skin diseases.
Imsidolimab is a recombinant research-use antibody directed against IL36R.